Reversing coma by senolytics and stem cells: the future is now.

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cellular Biology

Background:

• Global cerebral ischemia (GCI) is a primary cause of coma and disorders of consciousness (DoC).
• Patient recovery potential is often underestimated due to outdated views on neurogenesis.
• Emerging evidence suggests residual mental activity and communication in comatose patients.

Purpose of the Study:

• To propose a novel therapeutic strategy for reversing disorders of consciousness.
• To leverage recent advances in neurophysiology, regenerative medicine, and senescence biology.
• To offer a realistic chance of recovery for patients with GCI-induced coma.

Main Methods:

• A two-step therapeutic paradigm is proposed.
• Step 1: Utilize senolytic approaches to clear senescent cells and reduce neuroinflammation.
• Step 2: Stimulate neural regeneration via stem cell therapies, electrophysiologic, and pharmacological stimulation.

Main Results:

• This integrated approach aims to address the challenge of coma reversal.
• The strategy targets both neuroinflammation and neural regeneration.
• Experimental interventions are proposed based on current scientific understanding.

Conclusions:

• A novel treatment paradigm integrating senolytics and regenerative medicine is presented.
• This approach offers a potential pathway to reverse disorders of consciousness.
• The strategy addresses the limitations of historical treatment perspectives for coma patients.